Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Faze Three Ltd. Investor Presentation 2026

May 25, 2026

62686_rns_2026-05-25_1dce53f8-2434-48bb-97f9-93bd68d239b2.pdf

Investor Presentation

Open in viewer

Opens in your device viewer

F A Z E
L I M I T E D

May 25, 2026

To,

| BSE Limited Department of Corporate Services, P. J. Towers, Dalal Street, Mumbai – 400 001.
Scrip Code: 530079 | National Stock Exchange of India Limited Listing Compliance Department, Exchange Plaza, Plot No. C/ 1, G Block, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051.
Symbol: FAZE3Q |
| --- | --- |

Dear Sir/Ma’am,

Sub: Submission of Investor Presentation of the Company on the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2026

Ref: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Please find enclosed herewith the Company’s presentation on the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2026.

You are requested to kindly take the same on record and bring it to the notice of your constituents.

Thanking you,

Yours Sincerely,

For Faze Three Limited

SANJAY ANAND
Digitally signed by
SANJAY ANAND
Date: 2026.05.25
08:37:41 +05'30'

SANJAY ANAND
Whole-time Director
DIN: 01367853

FAZE THREE LIMITED
(CIN: L99999DN1985PLC000197)
Regd. Office: Survey 380/1, Khanvel Silvassa Road, Dapada, Silvassa – 396 230, UT of D&NH
Corporate Office: 63/64, 6th Floor, Wing C, Mittal Court, Nariman Point, Mumbai - 400021.
Tel. : 91 (22) 43514444, 66604600 * Fax : 91 (22) 24936811 * E-mail : [email protected] * Website : www.fazethree.com


img-0.jpeg

Investor Presentation

Financial Results — Quarter & Year Ended March 31, 2026

May 23, 2026


F A Z E

Why Faze Three

INR 933 Cr

FY26 Revenue

+33% YoY

INR 1,650+ Cr

Installed Revenue Capacity (all units). Additional Capex planned in FY 27 to scale higher with new categories added given gestation period of 1-1.5 years ~55% avg utilisation

INR 360+ Cr

Capex from Internal

Accruals since FY20

Major capex concluding FY27

Operating Leverage Ahead

55% average utilisation across INR 1,650+ Cr capacity. Revenue can nearly double without significant new capex. Major capex cycle concluding FY27.

Blue-Chip Customer Base

Walmart, Target, TJMax group, Action, Costco, Williams Sonoma, Pottery Barn, JYSK, Sainsbury's, etc. — Top 15 customers with 20+ year relationships. Built-in demand pipeline.

Cash Flow Inflection

With capex concluding, 40-50% of CFO available for debt reduction, dividends or growth. Net Debt/EBIDTA at 2.59x, manageable with rising earnings.

China+1 Structural Tailwind

CNYINR up 21% in 13 months. 10% tariff differential. Top retailers actively diversifying 15-20% out of China within 2-3 years. India is the primary beneficiary.

Vertically Integrated Moat, Order backed manufacturing

Yarn to finished product capability across Cotton and MMF. 8 factory locations. Replacement cost INR 800+ Cr — significant barrier for new entrants Company undertakes 100% Order backed manufacturing only

PLI & Trade Deal Catalysts

Applied for PLI for MMF, approval expected Q1/Q2 FY27. US-India, EU & UK trade deals in place. Tariff refunds to boost retail demand H2 CY27.

Est. 1985 • Listed 1995 • CARE A (Stable) / A1 • Home & Technical Textiles • Order-backed manufacturing


F A Z E

Company at a Glance

Operations

  • Engaged in manufacturing of Technical & Home Textiles products
  • Direct exports to large retailers in USA, UK & EUR — over 90% export revenue
  • 8 factory locations: Silvassa (2), Vapi (1), Panipat (4), Aurangabad (1)
  • Office + Showroom in New York, USA (Faze3 USA LLC)
  • Equal capabilities across Cotton & Polyester/MMF products
  • Order-backed manufacturing only; ~85% FOB; turnaround 60-120 days
  • Globally mandated infrastructure and operations standards

Market & Customer Profile

img-1.jpeg

  • Strong 20+ year relationships with Top 15 customers
  • Top 12 customers contribute ~80% of revenue
  • No single customer exceeds 15% of revenue
  • Most customers procure multiple products across factories
  • Customer appetite at least 10x current volumes — huge unfulfilled demand

Product Categories

  • Floor coverings: Bathmats, Rugs — Rubber backed
  • Performance & Outdoor Home Textiles (micro polyester, cushions)
  • Top of Bed, Blankets, Curtains, Accessories
  • Handloom: Accent Rugs, Throws, Power-loom rugs
  • Vertically integrated: Yarn to Finished Product
  • Inhouse Design, Development & Innovation capability

Competitive Edge

  • Multiple product lines (unique vs peers)
  • China cost + tariff arbitrage neutralised
  • Adequate room for all Indian peers
  • Most peers in only 1 product category

Management: Founder/Promoters + Professional CXOs • CARE Rated A (Stable) / A1 (Sept 2025) • Factory replacement value > INR 800 Crs


F A Z E
S E M I T R O

Our Valued Customers

Walmart® TARGET HMOX® ACTION JYSK® Sainsbury's DOLLAR GENERAL
Ruggable WILLIAMS SONOMA
04.11.2014 RUSTA PREFERRED LANDS' END® Dunelm ASDA
Marshalls Argos west elm pottery barn kids next HomeGoods Bant's, Bitterly*
Garnet Hill
FRONTGATE sam's club Dillard's
The Style of Your Life. DKNY
DIONNA KARIAN NEW YORK C. J. DIX Loblaws DESTORATION
HARDWARE
COSTCO
WHOLESALE MYER
MY STORE PRIMARK® JCPenney MIGROS M&S freedom
VOSSSEN AQUANOVA spirella® Kas

F A Z E
LIMITEH

Product Portfolio

www.fazethree.com

img-2.jpeg
img-3.jpeg
img-4.jpeg
img-5.jpeg
img-6.jpeg
img-7.jpeg
img-8.jpeg
img-9.jpeg
img-10.jpeg
img-11.jpeg
img-12.jpeg
img-13.jpeg


F A Z E

Market Opportunity

China +1 Acceleration

CNYINR moved from 11.65 to 14.10 (+21%) in 13 months — major cost advantage for India. Top retailers targeting 15-20% diversification from China within 2-3 years. 25%+ differential for EUR/GBP buyers. Combined with 10% tariff differential, this is the strongest tailwind in a decade.

India preferred diversifier under China+1

Commitments from large retailers like Walmart to source $ 30Bn by 2030. Most retailers prefer India as country diversification option versus China

Worlds largest democracy & politically stable large economy

Labour costs tailwind versus peers like China

India's MMF Opportunity

India leads in cotton home textiles but MMF (Floor coverings, Rugs, Outdoor, Performance textiles, TOB, Curtains) is dominated by China. India's MMF exports potential is estimated at 20x current levels. PLI for MMF will build the optimum supply chain.

As India consumes more Oil over the years the RM availability for downstream industries will drive economy of scale and pricing parity with global markets

Trade Deals in Place

US-India bilateral deal: tariffs at max 18%. Currently 10% post SC judgment. FTA with EU and UK are additional positives. Tariff refunds expected to boost retail demand H2 CY27 as retailers pass on savings. Full effect visible over 1-2 years.

Supplier Landscape

Other supplier countries (Turkey, Egypt, Pakistan, Bangladesh) face structural challenges — currency instability, infrastructure gaps, quality issues — driving customer preference towards India. Brownfield expansion is the key to capturing demand.

Supply chain opportunity

With significant scale of operations / business coming to Indian Companies, the Retailers would prefer to establish supply chain for moving larger value businesses across Textile Trade from hereon eg: Foxconn to India

Post energy crises caused by West Asia, Supply Chains will again reroute and tilt in favor of India given the stability and neutrality


F A Z E

Capitalizing on the Global Opportunity

INR 360+ Crs invested from internal accruals since FY20

img-14.jpeg

  • INR 25+ Cr invested in Rooftop Solar 3.5 MW (captive), PNG clean energy for processing & Li-ion Electric MHE — ESG focus
  • CARE credit rating reaffirmed A(Stable)/A1 (Sept 2025). Factory replacement value >INR 800 Crs — significant entry barrier
  • Focus on reducing costs, being innovative and most competitive manufacturer while maintaining budgeted net profit margins
  • Strong domestic supplier partnerships with upfront payment terms securing quality and timely supplies from best in business
  • Company's current planned capex expected to conclude in FY27. At least 40-50% of CFO available for alternative uses ahead

FA72E

Management Outlook — FY27 & Beyond

Q4FY26: Highest-ever quarterly Revenue (280 Cr) & EBIDTA (37 Cr) • FY26 Revenue +33% YoY despite tariff disruption Apr '25 – Feb '26 and significant uncertainty

Growth Trajectory

High volume growth momentum expected to continue in FY27/FY28 alongside inflation-related pricing growth (akin to FY22/23 cycle). Revenue growth expected higher than past CAGR trajectory. Strong long-term customer relationships and company's resilience/flexibility proved in yet another stress test.

Margin Recovery

EBIDTA margin rebounded to 13.25% in Q4FY26 vs 9.15% in Q3FY26 — driven by operating leverage at higher revenue, unwinding of tariff impacts, better USDINR, and improving trade deal sentiment. Margins should continue improving as revenue scales.

PLI & Capex

PLI application for MMF filed under amended scheme based on capex eligibility over last 4 years. Approval expected Q1/Q2 FY27. Planned annual capex ~INR 75 Crs in FY27 for additional new product capabilities by Q1FY28. Major capex cycle concluding FY27 — freeing 40-50% of CFO for alternative uses.

Tariff Landscape

All US tariffs at 10% post SC judgment. S 301 may settle at max 18% (bilaterally agreed) — already absorbed. Tariffs on China at 20% (10% + 10% Fentanyl). Tariff refunds expected to boost demand in H2 CY27 as retailers pass savings to consumers.

Input Cost Watch for H1FY27: US-Iran war has pushed Cotton, Polyester, chemicals, fuel, packaging, and logistics costs 25-35% higher from pre-war levels, only partially offset by USDINR realization. Company actively requesting reprice/upcharges with customers. Business momentum largely unaffected; customer feedback remains positive.


PAZ E LIMITED

P&L Summary — Quarterly

Consolidated • INR Crs

Particulars Q4 FY26 Q3 FY26 Q4 FY25 YTD FY26 YTD FY25 FY26 vs FY25 Q4 vs Q4
Total Income 280.4 229.3 218.2 932.8 701.7 33% 28%
EBIDTA 37.16 20.99 32.23 92.24 92.22 0.02% 15%
EBIDTA margin % 13.25% 9.15% 14.77% 9.89% 13.14%
Depreciation 7.96 7.90 6.86 30.7 25.0
Finance Cost 6.06 4.65 4.08 19.5 14.5
PBT 23.1 8.4 21.3 42.0 52.6 -20% 9%
PAT 19.6 6.4 17.4 33.6 40.7 -17% 13%
PAT margin % 7.0% 2.8% 8.0% 3.60% 5.79%
Cash Profit 27.6 14.3 24.3 64.4 65.7 -2% 14%
Cash Profit margin % 9.8% 6.2% 11.1% 6.90% 9.36%

Q4FY26 Revenue & EBIDTA were the highest-ever quarterly figures for the company.

EBIDTA margin rebounded closer to normal expected levels owing to unwinding of tariff impacts (after mid-Feb 2026), USDINR rates, and EU/USA trade deals improving sentiment since Jan 2026.

Revenue YOY growth of 33% was aided by share of CIF compared to last year to the extent of 7-8%.


F A Z E

P&L Summary — Annual

Consolidated • INR Crs

Particulars FY26 FY25 FY24 FY23 FY22 FY21 FY20
Total Income 932.8 701.7 572.3 563.8 511.4 326.7 306.3
Growth % 32.9% 22.6% 11.9% 10.2% 56.5% 6.7% 13.3%
EBIDTA 92.27 92.23 94.27 99.93 86.6 47.9 37.8
EBIDTA margin % 9.89% 13.14% 16.47% 17.73% 16.93% 14.67% 12.32%
Depreciation 30.7 25.0 20.6 14.5 10.2 8.8 8.0
Finance Cost 19.5 14.6 11.3 7.8 5.0 3.8 8.6
PBT 42.1 52.7 62.4 77.6 71.4 35.3 21.2
PAT 33.6 40.7 46.6 58.3 51.1 25.0 18.1
PAT margin % 3.60% 5.79% 8.15% 10.34% 9.99% 7.7% 5.9%
Cash Profit 64.3 65.7 67.2 72.8 61.3 33.8 26.1
Cash Profit margin % 6.9% 9.4% 11.7% 12.9% 12.0% 10.4% 8.5%
EPS (INR) 13.8 16.7 19.2 24.0 21.0 10.3 7.5
EPS growth % -17.4% -12.8% -20.0% 14.2% 104.2% 38.0% 20.5%
Cash EPS 26.5 27.0 27.7 29.9 25.2 13.9 10.7
Cash EPS growth % -2.1% -2.3% -7.6% 18.8% 81.0% 29.7% 28.8%

The company expects Revenue CAGR to continue ahead. FY27/FY28 will see higher growth from volume + inflation impulse. EBIDTA margins should improve as operating leverage kicks in at higher revenue levels post resolution of West Asia crises (widely expected May/June 2026). FY26 EBIDTA was impacted owing to impact related to Trade tariffs from April 25 to Feb 26).

6-Year CAGR

Revenue 20%

EBIDTA 16%

EPS 11%

Cash EPS 16%

img-15.jpeg


F A Z E L I M I T E N

Balance Sheet Summary – Annual

Consolidated • INR Crs

Particulars Mar 31, 2026 Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021 Mar 31, 2020
Networth^ 452.3 420.0 380.6 334.6 278.3 226.1 201.5
Non-Current liabilities 47.6 9.9 8.7 6.8 5.3 1.7 2.6
ST Borrowings (Net)* 175.3 160.7 74.0 44.3 77.1 48.9 37.2
Current liabilities 107.5 69.7 39.4 33.1 38.7 28.4 16.7
Total Liabilities 782.7 660.3 502.6 418.8 399.3 305.1 258.0
Net Fixed Assets^ 366.8 299.3 240.5 208.4 157.1 132.9 125.4
Non-Current Assets 48.5 24.5 18.4 9.3 15.6 7.4 12.4
Current Assets (Excl Cash)* 367.4 336.5 243.7 201.1 226.7 164.8 120.2
Total Assets 782.7 660.3 502.6 418.8 399.3 305.1 258.0
Core Capital Employed#^ 623.6 538.9 407.2 329.3 304.3 221.7 186.0
*Cash & Cash Eq / Liquid Invst 30.9 19.6 82.6 116.28 80.58 42.46 16.29

^ includes INR 51.63 of Land Revaluation Reserve • # Core capital employed excludes revaluation of INR 51.63 and Current Liabilities • *Excludes Cash and Cash Equivalents and unsecured payables financing included in current liabilities


F A Z E

Key Ratios Summary

Consolidated

Return Ratios FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19
ROE^ 8% 11% 14% 21% 23% 15% 10% 13%
Core ROCE #^ 11% 14% 20% 27% 29% 19% 13% 15%
Operating Ratios FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19
Current Ratio 3.4 4.8 6.2 6.1 5.9 5.8 7.2 7.2
Fixed Asset Turnover 3.0 2.8 3.1 3.7 5.1 4.2 3.8 4.1
Total Asset Turnover 1.3 1.2 1.3 1.6 1.5 1.3 1.3 1.4
Inventory days 78 112 96 61 96 88 88 98
Debtor days 45 48 49 64 59 78 60 62
Payable days 24 23 15 12 18 17 10 13
Cash Conversion Cycle 99 137 130 113 137 149 138 147
Solvency Ratios FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19
Outside Liab / Equity 0.71 0.55 0.30 0.23 0.42 0.34 0.27 0.34
Net Debt / Equity 0.48 0.38 0.19 0.13 0.28 0.22 0.18 0.25
Net Debt / EBIDTA 2.33 1.74 0.78 0.44 0.89 1.02 1.25 1.48
Interest Coverage 3.16 4.62 6.55 10.90 15.31 10.37 3.64 3.65

^INR 51.63 Crs Land Revaluation Reserve excluded for ROE & Core ROCE. Revenue, EBIDTA and PAT considered. #Average Core Capital Employed for Core ROCE. Interest coverage on gross finance cost.


F A Z E L I M I T E M

Cash Flow Summary

Consolidated • INR Crs

Particulars Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Cumul. 2020-26
PAT + Depn + non-cash adj 64.3 65.7 67.2 72.8 61.3 33.8 26.1 391.2
Working capital changes 6.9 -61.3 -34.5 21.6 -48.0 -34.0 0.8 -148.4
CF from Operations 71.2 4.4 32.7 94.4 13.3 -0.1 27.0 282.0
CF Investing & Fixed assets -98.3 -83.8 -52.7 -65.9 -34.4 -16.3 -12.4 -363.7
CF Non-Current Assets 13.7 -6.1 -9.1 6.3 -8.2 5.0 -3.2 -1.6
CF Borrowings/financing 14.6 86.7 29.7 -32.8 28.2 11.7 -9.5 128.6
CF Dividend -1.2 -1.5 -2.7
CF change for year 1.3 1.3 0.6 2.0 -2.2 -1.2 1.9 3.6

Capital Allocation — Looking Ahead

INR 363.7 Cr of cumulative CFO invested in capex over 6 years — building INR 1,650+ Cr revenue capacity from INR 306 Cr base.

Major capex cycle expected to conclude in FY27. This would make at least 40-50% of CFO available for alternative uses — debt reduction, working capital optimisation, or shareholder returns.

ESG investments: INR 25+ Cr in Rooftop Solar 3.5 MW, PNG clean energy, Li-ion Electric MHE. Additional ESG capex committed in FY27.

Strong domestic supplier partnerships with upfront payment terms securing quality and timely supplies from best-in-class vendors.


img-16.jpeg

Thank you

Faze Three Group

Awards & Recognition

Winner of D&B "Business Enterprises of Tomorrow 2025" — Best Global Business (Mid-Corporate). CARE Rating reaffirmed A(Stable)/A1 (Sept 2025).

Akram Sati
[email protected] | 022 43514444
Corporate office: 63, C Wing, Mittal Court, Nariman Point, Mumbai 400021

14


F A Z E L I M I T E M

Disclaimer

The information contained in this presentation is provided by Faze Three Limited (the "Company"), although care has been taken to ensure that the information in this presentation is accurate, and that the opinions expressed are fair and reasonable, the information is subject to change without notice, its accuracy, fairness or completeness is not guaranteed and has not been independently verified and no express or implied warranty is made thereto. You must make your own assessment of the relevance, accuracy and adequacy of the information contained in this presentation and must make such independent investigation as you may consider necessary or appropriate for such purpose. Neither the Company nor any of its directors assume any responsibility or liability for, the accuracy or completeness of, or any errors or omissions in, any information or opinions contained herein. Neither the Company nor any of its directors, officers, employees or affiliates nor any other person accepts any liability (in negligence, or otherwise) whatsoever for any loss howsoever arising from any use of this presentation or its contents or otherwise arising in connection therewith. The statements contained in this document speak only as at the date as of which they are made, and the Company expressly disclaims any obligation or undertaking to supplement, amend or disseminate any updates or revisions to any statements contained herein to reflect any change in events, conditions or circumstances on which any such statements are based. This document is for informational purposes and does not constitute or form part of a prospectus, a statement in lieu of a prospectus, an offering circular, offering memorandum, an advertisement, and should not be construed as an offer to sell or issue or the solicitation of an offer or an offer document to buy or acquire or sell securities of the Company or any of its subsidiaries or affiliates. No part of this document should be considered as a recommendation that any investor should subscribe to or purchase securities of the Company. This presentation contains statements of future expectations and other forward-looking statements which involve risks and uncertainties. Such forward-looking statements are not guarantees of future performance and actual results may differ. You are cautioned not to place undue reliance on these forward looking statements. The Company does not assume any responsibility to amend, modify or revise any forward-looking statements, on the basis of any subsequent developments, information or events, or otherwise.

15